KW-3357 Study in Patients With Early Onset Severe Preeclampsia
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of intravenous KW-3357 in patients with
early-onset severe preeclampsia by comparing the prolongation days of pregnancy with that of
placebo.